P2.06-34 Inhibition of the HGF/c-Met Pathway for Malignant Mesothelioma With an Intra-Thoracic Injection of the NK4 Expressing Adenoviral Vectors

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1289
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2013English

P2.06-42 AXL, C-Met and VEGFR2 Tyrosine Kinase Receptors as Therapeutic Targets in Malignant Pleural Mesothelioma.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Inhibition of Mesothelioma Cancer Stem-Like Cells With Adenovirus-Mediated NK4 Gene Therapy

International Journal of Cancer
Cancer ResearchOncology
2014English

Targeting the HGF/c-Met Axis: State of Play

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Interruption of the HGF Paracrine Loop by NK4, an HGF Antagonist, Reduces VEGF Expression of CT26 Cells

Oncology Reports
MedicineCancer ResearchOncology
2013English

P2.06-33 Heterogeneity in Care Pathways for Patients With Malignant Pleural Mesothelioma Presenting at a Quaternary Thoracic Oncology Center in Quebec

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-15 Malignant Pleural Mesothelioma in Young Adult People in Uganda

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.06-27 Extrapleural Pneumonectomy, Radiation Therapy, and Chemotherapy for Epithelioid Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Thoracic Computed Tomography Findings in Malignant Mesothelioma

Iranian Journal of Radiology
Nuclear MedicineRadiologyImaging
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy